Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cells.
about
Reactive Oxygen Species and Targeted Therapy for Pancreatic CancerMechanisms of disseminated cancer cell dormancy: an awakening fieldTumor cell dormancyDesign and synthesis of a library of lead-like 2,4-bisheterocyclic substituted thiophenes as selective Dyrk/Clk inhibitorsMirk/dyrk1B kinase is upregulated following inhibition of mTOR.Updates of reactive oxygen species in melanoma etiology and progression.Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells.The Tumor Suppressor NKX3.1 Is Targeted for Degradation by DYRK1B KinaseThe Relevance of Nrf2 Pathway and Autophagy in Pancreatic Cancer Cells upon Stimulation of Reactive Oxygen Species.Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition.A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma.Cancer metastasis - tricks of the trade.Superoxide Dismutases in Pancreatic Cancer.A novel DYRK1B inhibitor AZ191 demonstrates that DYRK1B acts independently of GSK3β to phosphorylate cyclin D1 at Thr(286), not Thr(288).A wake-up call to quiescent cancer cells - potential use of DYRK1B inhibitors in cancer therapy.The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation.MuvB: A Key to Cell Cycle Control in Ovarian Cancer.
P2860
Q26765827-05677255-D32E-40B8-A274-CA8923B19DC3Q27027015-949068E3-5101-4D89-B633-E2B9BBD445ADQ28073065-B8A609D7-FB58-46EA-84DA-66675628D034Q28541616-EAC9D5A2-1D03-460D-A0E4-0C6E5BA040E2Q34096774-748F6BDF-83FE-414B-BD42-42559CD4AFDBQ34403921-F30E8188-5F64-41F0-B448-F14043DA2324Q34405468-D279902D-3221-488E-B669-B8317DD26FEDQ35578920-0C1C1C93-6EEA-4889-BFC4-2CE2545FA465Q36349182-0199FAC1-E816-483D-89BB-9D63685238CFQ36650727-677F832C-F720-4636-9D2C-32EA44422CBAQ37379468-13DCBE9B-977D-4543-8A0C-135D3EFD952DQ39171071-2B1320C8-DD9A-4B8A-BCC4-BDFB4282E152Q41662731-278022DA-5023-46B9-A7AD-3660563E64FEQ42708880-1D6A2398-5D55-4877-9AAF-6796448A0F9DQ46250363-EF0427DA-1F4D-4762-ADAE-71DEAB7BA63CQ52608415-DE48ACA3-F983-4F67-895D-326974F9B718Q55286778-9F7CDAA0-C8E5-4B60-9219-4E94D35300EC
P2860
Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cells.
@ast
Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cells.
@en
type
label
Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cells.
@ast
Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cells.
@en
prefLabel
Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cells.
@ast
Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cells.
@en
P2093
P2860
P1476
Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cells.
@en
P2093
Ann F Hoffman
Ann Polonskaia
Daina Z Ewton
Eileen A Friedman
John F Boylan
Karen Zipf
Kin-Chun Luk
Maria Vilenchik
Xiaobing Deng
P2860
P304
P356
10.1158/1535-7163.MCT-11-0498
P577
2011-08-30T00:00:00Z